Moreover, treatment of human WISH epithelial cell line with either recombinant IFNα or plasma derived from SLE patients upregulated the expression of these 3 genes (36), suggesting a direct association between the calculated type I IFN score and IFN-α pathway activity. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.